July 15, 2013 5:09 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of operating margin.The trailing-twelve-month operating margin at United Therapeutics (NASDAQ: UTHR) is 43.33%. United Therapeutics had $670.64 million in total cash for the latest quarter.The trailing-twelve-month operating margin at Warner Chilcott plc (NASDAQ: WCRX) is 33.44%. Warner Chilcott's revenue for the same period is $2.45 billion.The trailing-twelve-month operating margin at Endo Health Solutions (NASDAQ: ENDP) is 27.96%. Endo Health's ROA for the same period is 8.04%.The trailing-twelve-month operating margin at Cubist Pharmaceuticals (NASDAQ: CBST) is 23.38%. Cubist's ROE for the same period is 13.62%.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.